Electronic cigarette use and harm reversal: Emerging evidence in the lung

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Polosa, Riccardo ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

E cigarette; E vapor products; Harm reversal; Lung function; Respiratory system; Smoking cessation; Tobacco harm reduction

Indexed keywords

CIGARETTE SMOKE;

AIRBORNE PARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; CYTOTOXICITY; ELECTRONIC CIGARETTE; ENVIRONMENTAL EXPOSURE; GENOTOXICITY; HARM REDUCTION; HUMAN; INFLAMMATION; LUNG DISEASE; MUTAGENICITY; NOTE; OXIDATIVE STRESS; QUALITY OF LIFE; SMOKING CESSATION; THROAT IRRITATION; LUNG DISEASES; TOBACCO USE DISORDER;

ELECTRONIC CIGARETTES; HARM REDUCTION; HUMANS; LUNG DISEASES; TOBACCO USE DISORDER;

EID: 84928235023     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0298-3     Document Type: Note

References (23)

1. Mangan D. E-cigarette sales are smoking hot, set to hit $1.7 billion. CNBC. 2013. Retrieved 28th August 2014 from http://www.cnbc.com/id/100991511 .
2. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health. 2014;11:4356-73.
3. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking cessation tool: Results from an online survey. Am J Prev Med. 2011;40:472-5.
4. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8:e66317.
5. Polosa R, Caponnetto P, Maglia M, Morjaria JB, Russo C. Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health. 2014;14:1159.
6. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17:127-33.
7. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarettes substitutes: a systematic review. Ther Adv Drug Safety. 2014;5:67-86.
8. Hecht SS, Carmella SG, Kotandeniya D, Pillsbury ME, Chen M, Ransom BW, et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-Cigarette users versus cigarette smokers. Nicotine Tob Res. 2014; [Ahead of print].
9. Lee PN. Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol. 2011;59:197-214.
10. Misra M, Leverette RD, Cooper BT, Bennett MB, Brown SE. Comparative in vitro toxicity profile of electronic and tobacco cigarettes, smokeless tobacco and nicotine replacement therapy products: e-liquids, extracts and collected aerosols. Int J Environ Res Public Health. 2014;11:11325-47.
11. Cervellati F, Muresan XM, Sticozzi C, Gambari R, Montagner G, Forman HJ, et al. Comparative effects between electronic and cigarette smoke in human keratinocytes and epithelial lung cells. Toxicol In Vitro. 2014;28:999-1005.
12. Polosa R, Campagna D, Tashkin D. Subacute bronchial toxicity induced by an electronic cigarette: take home message. Thorax. 2014;69:588.
13. Vardavas C, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly G, Behrakis P. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest. 2012;141:1400-6.
14. Oostveen E, MacLeod D, Lorino H, Farré R, Hantos Z, Desager K, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22:1026-41.
15. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602-15.
16. Flouris A, Chorti M, Poulianiti K, Jamurtas A, Kostikas K, Tzatzarakis M, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25:91-101.
17. Morjaria JB, Malerba M, Polosa R. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD. Drug Discov Today. 2010;15:396-405.
18. Holgate ST, Polosa R. Treatment strategies for allergy and asthma. Nat Rev Immunol. 2008;8:218-30.
19. Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41:716-26.
20. Polosa R, Morjaria JB, Caponnetto P, Caruso M, Strano S, Battaglia E, et al. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. Int J Environ Res Public Health. 2014;11:4965-77.
21. Caponnetto P, Polosa R, Russo C, Leotta C, Campagna D. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Rep. 2011;5:585.
22. Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014;20:218-25.
23. Saitta D, Ferro GA, Polosa R. Achieving appropriate regulations for electronic cigarettes. Ther Adv Chronic Dis. 2014;5:50-61.